Citation 145905

MIRANDA,CL: STEVENS,JF: IVANOV,V: MC CALL,M: FREI,B: DEINZER,ML: BUHLER,DR:. (2000). ANTIOXIDANT AND PROOXIDANT ACTIONS OF PRENYLATED AND NONPRENYLATED CHALCONES AND FLAVANONES IN VITRO.. 48()

Citation Details

Title	ANTIOXIDANT AND PROOXIDANT ACTIONS OF PRENYLATED AND NONPRENYLATED CHALCONES AND FLAVANONES IN VITRO.
Authors	MIRANDA,CL: STEVENS,JF: IVANOV,V: MC CALL,M: FREI,B: DEINZER,ML: BUHLER,DR:
Year	2000
Volume	48
Issue

Summary

Year: 2000

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL	ACTIVE
2	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL	ACTIVE
3	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-4-4'-6-TETRAHYDROXY-3'-C-PRENYL:	ACTIVE
4	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-4-4'-6-TETRAHYDROXY-3'-C-PRENYL:	ACTIVE
5	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOGALENOL	INACTIVE
6	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOGALENOL	ACTIVE
7	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
8	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
9	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,8-GERANYL:	WEAK ACTIVITY
10	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,8-GERANYL:	ACTIVE
11	PROOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,8-GERANYL:	ACTIVE
12	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,6-GERANYL:	INACTIVE
13	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,6-GERANYL:	ACTIVE
14	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,4'-O-METHYL:	ACTIVE
15	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,4'-O-METHYL:	ACTIVE
16	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-4-DIHYDROXY-4'-6'-DIMETHOXY:	ACTIVE
17	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN	ACTIVE
18	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE
19	PROOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	ACTIVE
20	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,6-8-DIPRENYL:	INACTIVE
21	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,6-8-DIPRENYL:	ACTIVE
22	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,8-PRENYL:	INACTIVE
23	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,8-PRENYL:	ACTIVE
24	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,ISO:	INACTIVE
25	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,ISO:	ACTIVE
26	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,6-PRENYL:	INACTIVE
27	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,6-PRENYL:	ACTIVE
28	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONARINGENIN	INACTIVE
29	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONARINGENIN	INACTIVE
30	PROOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONARINGENIN	ACTIVE
31	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMUL,4'-O-5'-C-DIPRENYL:	ACTIVE
32	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,TETRAHYDRO:	ACTIVE
33	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,TETRAHYDRO:	ACTIVE
34	LDL OXIDATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,5'-PRENYL:	INACTIVE
35	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,5'-PRENYL:	ACTIVE

Citation 145905

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1